PAWR and cancer: The fundamental discovery that Par-4 can be secreted (by both normal and cancer cells), and that the secreted Par-4 exhibits a bystander apoptotic effect (only in cancer cells) has produced a wonderful ‘hot spot’ to target Par-4 for cancer-selective therapeutics.